Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.decode launches DNA based prostate cancer test
deCODE believes the test will be useful for better predicting risk of prostate cancer, helping to optimize both screening and treatment. deCODE PrCa detects a total of six
deCODE believes the test will be useful for better predicting risk of prostate cancer, helping to optimize both screening and treatment. deCODE PrCa detects a total of six
Under the terms of the financing, GTC will also issue 7-year warrants to purchase an additional share of GTC’s common stock for each share sold in the offering,
APP’s bleomycin sulfate is AP-rated, preservative and latex-free, and bar-coded at the individual unit-of-use. It has been shown to be useful in the management of the following neoplasms
The NDA for Entereg 12mg capsules is for in-hospital, short-term use for the management of postoperative ileus (POI). Specifically, the proposed indication is for the acceleration of upper
The proposed human studies with plasmid-delivered Growth Hormone Releasing Hormone (GHRH) follow successful studies in dogs with cancer. Administration of GHRH plasmid with VGX’s Cellectra electroporation device was
In connection with the transaction, structured as a reverse merger, Alynx issued approximately 52.9 million new shares of its common stock, and approximately 3.7 million new shares of
Under the letter of intent, Northwest Hospital will house the new facility on its 33-acre, north Seattle campus and will become an equity partner in the project. The
Orphan drug designation entitles arGentis Pharmaceuticals to seven years of marketing exclusivity for ARG201(native type 1bovine collagen) upon regulatory approval, as well as the opportunity to apply for
Mylan will make its products available to pharmacies in Florida as soon as motions and procedural steps surrounding its removal from the negative formulary are satisfied. Florida’s Board
As of the expiration of the tender offer, a total of approximately 25,491,221 shares of Ventana common stock were tendered and not withdrawn, representing approximately 70.5% of Ventana’s